Enhancement of plasmid DNA immunogenicity with linear polyethylenimine

European Journal of Immunology

Volumn 42, Issue 11, 2012, Pages 2937-2948

  Grant, Evita V ^a   Thomas, Mini ^b   Fortune, Jennifer ^c   Klibanov, Alexander M ^c   Letvin, Norman L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PURDUE UNIVERSITY   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Adjuvants; DNA; PEI; Polymers; Vaccines

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; PLASMID DNA; POLYETHYLENEIMINE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; GENE EXPRESSION; HUMORAL IMMUNITY; IMMUNOGENICITY; INOCULATION; LETHAL DOSE; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TH1 CELL;

ADAPTIVE IMMUNITY; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CYTOKINES; EPITOPES, T-LYMPHOCYTE; FEMALE; LISTERIA MONOCYTOGENES; LISTERIOSIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NANOPARTICLES; PLASMIDS; POLYETHYLENEIMINE; SPECIFIC PATHOGEN-FREE ORGANISMS; STATISTICS, NONPARAMETRIC; VACCINES, DNA;

EID: 84868110235     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242410     Document Type: Article

References (50)

1. Ulmer, J. B., Wahren, B. and Liu, M. A., DNA vaccines for HIV/AIDS. Curr. Opin. HIV AIDS 2006. 1: 309-313.
2. Liu, M. A. and Ulmer, J. B., Human clinical trials of plasmid DNA vaccines. Adv. Genet. 2005. 55: 25-40.
3. Kurath, G., Overview of recent DNA vaccine development for fish. Dev. Biol. (Basel). 2005. 121: 201-213.
4. Bergman, P. J., McKnight, J., Novosad, A., Charney, S., Farrelly, J., Craft, D., Wulderk, M. et al., Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clin. Cancer Res. 2003. 9: 1284-1290.
5. Turell, M. J., Bunning, M., Ludwig, G. V., Ortman, B., Chang, J., Speaker, T., Spielman, A. et al., DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus). Emerg. Infect. Dis. 2003. 9: 1077-1081.
6. Zur Megede, J., Otten, G. R., Doe, B., Liu, H., Leung, L., Ulmer, J. B., Donnelly, J. J. et al., Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines. J. Virol. 2003. 77: 6197-6207.
7. Wang, S., Farfan-Arribas, D. J., Shen, S., Chou, T. H., Hirsch, A., He, F. and Lu, S., Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine. Vaccine 2006. 24: 4531-4540.
8. Norman, J. A., Hobart, P., Manthorpe, M., Felgner, P. and Wheeler, C., Development of improved vectors for DNA-based immunization and other gene therapy applications. Vaccine 1997. 15: 801-803.
9. Mannino, R. J., Canki, M., Feketeova, E., Scolpino, A. J., Wang, Z., Zhang, F., Kheiri, M. T. and Gould-Fogerite, S., Targeting immune response induction with cochleate and liposome-based vaccines. Adv. Drug Deliv. Rev. 1998. 32: 273-287.
10. Garzon, M. R., Berraondo, P., Crettaz, J., Ochoa, L., Vera, M., Lasarte, J. J., Vales, A. et al., Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex. Vaccine 2005. 23: 1384-1392.
11. Iqbal, M., Lin, W., Jabbal-Gill, I., Davis, S. S., Steward, M. W. and Illum, L., Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice. Vaccine 2003. 21: 1478-1485.
12. Rottinghaus, S. T., Poland, G. A., Jacobson, R. M., Barr, L. J. and Roy, M. J., Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination. Vaccine 2003. 21: 4604-4608.
13. Sumida, S. M., McKay, P. F., Truitt, D. M., Kishko, M. G., Arthur, J. C., Seaman, M. S., Jackson, S. S. et al., Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. J. Clin. Invest. 2004. 114: 1334-1342.
14. Tudor, D., Dubuquoy, C., Gaboriau, V., Lefevre, F., Charley, B. and Riffault, S., TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines. Vaccine 2005. 23: 1258-1264.
15. Barouch, D. H., McKay, P. F., Sumida, S. M., Santra, S., Jackson, S. S., Gorgone, D. A., Lifton, M. A. et al., Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines. J. Virol. 2003. 77: 8729-8735.
16. Azzam, T. and Domb, A. J., Current developments in gene transfection agents. Curr. Drug Deliv. 2004. 1: 165-193.
17. Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B. and Behr, J. P., A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 1995. 92: 7297-7301.
18. Demeneix, B. and Behr, J. P., Polyethylenimine (PEI). Adv. Genet. 2005. 53: 217-230.
19. Kichler, A., Leborgne, C., Coeytaux, E. and Danos, O., Polyethylenimine-mediated gene delivery: a mechanistic study. J. Gene. Med. 2001. 3: 135-144.
20. Brunner, S., Furtbauer, E., Sauer, T., Kursa, M. and Wagner, E., Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol. Ther. 2002. 5: 80-86.
21. Ma, Y. F. and Yang, Y. W., Delivery of DNA-based cancer vaccine with polyethylenimine. Eur. J. Pharm. Sci. 2010. 40: 75-83.
22. Cubillos-Ruiz, J. R., Engle, X., Scarlett, U. K., Martinez, D., Barber, A., Elgueta, R., Wang, L. et al., Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. J. Clin. Invest. 2009. 119: 2231-2244.
23. Shim, B. S., Park, S. M., Quan, J. S., Jere, D., Chu, H., Song, M. K., Kim, D. W. et al., Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses. BMC Immunol. 2010. 11: 65.
24. Bivas-Benita, M., Bar, L., Gillard, G. O., Kaufman, D. R., Simmons, N. L., Hovav, A. H. and Letvin, N. L., Efficient generation of mucosal and systemic antigen-specific CD8+ T-cell responses following pulmonary DNA immunization. J. Virol. 2010. 84: 5764-5774.
25. Rice-Ficht, A. C., Arenas-Gamboa, A. M., Kahl-McDonagh, M. M. and Ficht, T. A., Polymeric particles in vaccine delivery. Curr. Opin. Microbiol. 2010. 13: 106-112.
26. Thomas, M., Lu, J. J., Ge, Q., Zhang, C., Chen, J. and Klibanov, A. M., Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc. Natl. Acad. Sci. USA 2005. 102: 5679-5684.
27. Goula, D., Becker, N., Lemkine, G. F., Normandie, P., Rodrigues, J., Mantero, S., Levi, G. and Demeneix, B. A., Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene. Ther. 2000. 7: 499-504.
28. Takahashi, H., Nakagawa, Y., Pendleton, C. D., Houghten, R. A., Yokomuro, K., Germain, R. N. and Berzofsky, J. A., Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant. Science 1992. 255: 333-336.
29. Ladel, C. H., Flesch, I. E., Arnoldi, J. and Kaufmann, S. H., Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T-cell responses on Listeria monocytogenes infection. J. Immunol. 1994. 153: 3116-3122.
30. Anwer, K., Earle, K. A., Shi, M., Wang, J., Mumper, R. J., Proctor, B., Jansa, K. et al., Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines. Pharm. Res. 1999. 16: 889-895.
31. Brockstedt, D. G., Podsakoff, G. M., Fong, L., Kurtzman, G., Mueller-Ruchholtz, W. and Engleman, E. G., Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. Clin. Immunol. 1999. 92: 67-75.
32. Pope, C., Kim, S. K., Marzo, A., Masopust, D., Williams, K., Jiang, J., Shen, H. and Lefrancois, L., Organ-specific regulation of the CD8 T-cell response to Listeria monocytogenes infection. J. Immunol. 2001. 166: 3402-3409.
33. Xiang, S. D., Scholzen, A., Minigo, G., David, C., Apostolopoulos, V., Mottram, P. L. and Plebanski, M., Pathogen recognition and development of particulate vaccines: does size matter? Methods 2006. 40: 1-9.
34. Cohen, J. A., Beaudette, T. T., Tseng, W. W., Bachelder, E. M., Mende, I., Engleman, E. G. and Frechet, J. M., T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size. Bioconjug. Chem. 2009. 20: 111-119.
35. Westwood, A., Healey, G. D., Williamson, E. D. and Eyles, J. E., Activation of dendritic cells by microparticles containing Bacillus anthracis protective antigen. Vaccine 2005. 23: 3857-3863.
36. Yoshikawa, T., Okada, N., Oda, A., Matsuo, K., Kayamuro, H., Ishii, Y., Yoshinaga, T. et al., Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells. Vaccine 2008. 26: 1303-1313.
37. Chollet, P., Favrot, M. C., Hurbin, A. and Coll, J. L., Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J. Gene. Med. 2002. 4: 84-91.
38. Anderson, D. G., Peng, W., Akinc, A., Hossain, N., Kohn, A., Padera, R., Langer, R. and Sawicki, J. A., A polymer library approach to suicide gene therapy for cancer. Proc. Natl. Acad. Sci. USA 2004. 101: 16028-16033.
39. Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A. and Felgner, P. L., Direct gene transfer into mouse muscle in vivo. Science 1990. 247: 1465-1468.
40. Nchinda, G., Amadu, D., Trumpfheller, C., Mizenina, O., Uberla, K. and Steinman, R. M., Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells. Proc. Natl. Acad. Sci. USA 2010. 107: 4281-4286.
41. Xiao, H., Peng, Y., Hong, Y., Liu, Y., Guo, Z. S., Bartlett, D. L., Fu, N. and He, Y., Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma. J. Immunol. 2011. 187: 1788-1796.
42. Ulmer, J. B., Fu, T. M., Deck, R. R., Friedman, A., Guan, L., DeWitt, C., Liu, X. et al., Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J. Virol. 1998. 72: 5648-5653.
43. Lekutis, C., Shiver, J. W., Liu, M. A. and Letvin, N. L., HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha. J. Immunol. 1997. 158: 4471-4477.
44. Fischer, D., Bieber, T., Li, Y., Elsasser, H. P. and Kissel, T., A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res. 1999. 16: 1273-1279.
45. Wightman, L., Kircheis, R., Rossler, V., Carotta, S., Ruzicka, R., Kursa, M. and Wagner, E., Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene. Med. 2001. 3: 362-372.
46. Ohana, P., Schachter, P., Ayesh, B., Mizrahi, A., Birman, T., Schneider, T., Matouk, I. et al., Regulatory sequences of H19 and IGF2 genes in DNA-based therapy of colorectal rat liver metastases. J. Gene. Med. 2005. 7: 366-374.
47. Sidi, A. A., Ohana, P., Benjamin, S., Shalev, M., Ransom, J. H., Lamm, D., Hochberg, A. and Leibovitch, I., Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. J. Urol. 2008. 180: 2379-2383.
48. NCI, Cancer Drug Information - Trastuzumab 2012 http://www.cancer.gov/cancertopics/druginfo/trastuzumab.
49. NCI, Cancer Drug Information - Rituximab 2012 http://www.cancer.gov/cancertopics/druginfo/rituximab.
50. Thomas, M. and Klibanov, A. M., Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc. Natl. Acad. Sci. USA 2002. 99: 14640-14645.